Healthcare - Biotechnology - NASDAQ - US
$ 15.39
-5.81 %
$ 779 M
Market Cap
-9.22
P/E
INCOME STATEMENT
0
REVENUE
-79.9 M
OPERATING INCOME
-69.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Tyra Biosciences, Inc.
| Revenue | 0 |
| Cost Of Revenue | 353 K |
| Gross Profit | -353 K |
| Operating Expenses | 79.9 M |
| Operating Income | -79.9 M |
| Other Expenses | -10.8 M |
| Net Income | -69.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.4 | 0.3 | 0.1 | 47 K | 8 K |
| Gross Profit | (0.4) | (0.3) | (0.1) | 47 K | 8 K |
| OPERATING INCOME | |||||
| Operating Expenses | 79.9 | 58.9 | 26.3 | 9.3 | 3.1 |
| Selling, General and Administrative Expenses | 17.4 | 15.9 | 5.7 | 2.1 | 1.3 |
| Research and Development Expenses | 62.5 | 43.0 | 20.6 | 7.2 | 1.8 |
| Operating Income | (79.9) | (58.9) | (26.3) | (9.3) | (3.1) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | (0.3) | 0 | 1 K | 1 K |
| Total Other Income | 10.8 | 3.6 | 6 K | 39 K | (0.9) |
| Pre-Tax Income | (69.1) | (55.3) | (26.3) | (9.3) | (4.1) |
| NET INCOME | |||||
| Tax Provision | 0 | (3.6) | (0.2) | 22 K | 7 K |
| Net Income | (69.1) | (51.7) | (26.1) | (9.3) | (4.1) |
| EPS | 1.62 | 1.23 | 0.63 | 0.22 | 0.0954 |